Philip Morris is locked in a £1bn battle with private equity firm Carlyle over drugmaker Vectura.
This entry was posted
on Tuesday, August 10th, 2021 at 7:09 am and is filed under Business.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.